Overview

The 22nd DIA Japan Annual Meeting 2025 will be held at Tokyo Big-Sight from October 19 to October 21, 2025.
The theme of this meeting is "Strong Ties of Japan with Asia and the World for Delivering ‘Tomorrow's Normal’ to Patients." With the globalization of medical care, including recent progress in the use of AI/digital technology for building more efficient ecosystems and processes worldwide, the environment surrounding the development and pharmacovigilance of drugs and other medical products is rapidly changing. In these circumstances, the Asian region plays a major role in the advancement of healthcare systems around the world, and further collaboration among Japan, Asia, and the world will promote medical innovation and provide innovative medical products to patients.
This year's meeting offers an opportunity for all local and global stakeholders who are considering the future of medical care to strengthen their partnerships, including cross-border cooperation, to promote innovation and advance medical care by sharing their knowledge and experiences. At this meeting, we will collaborate together to create “Tomorrow’s Normal” in which everyone can feel peaceful and lead vibrant and healthy lives.
This year’s meeting has also established an English-language track to enable more globally interactive sessions with local and overseas experts, generate active discussions on ways to further advance medical innovation through sharing the latest knowledge on the current medical product development and post-marketing environments, and strengthen cooperation among Japan, Asia, and the world.
We invite you to share your knowledge and experience at the 22nd DIA Japan Annual Meeting 2025 so that we can think together about “Delivering ‘Tomorrow’s Normal’ to Patients,” and sincerely look forward to your active participation.
Program Committee
-
Yasuhiro Fujiwara, MD, PhD Chief Executive
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Keiko Tsumori, MSc Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
MSD K.K., Japan -
Yoshiaki Uyama, PhD, MS, RPh Associate Executive Director
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Asami Ezaki, MS Division Director, PR Section, Office of Planning and Operations
Pharmaceuticals and Medeical Devices Agency (PMDA), Japan -
Hiroya Nakamura Employee
Pharmaceuticals and Medical Devices Agency, Japan -
Yuko Hata Associate director, Therapeutic Area Regulatory, Japan Regulatory Affairs
Takeda Pharmaceutical Company, Japan -
Masaaki Jitsu
Bayer Yakuhin Ltd, Japan -
Yuki Kai, MBA Clinical Strategy and Resource Management Department, Clinical Development Divis
Chugai Pharmaceutical Co., Ltd.,, Japan -
Yusuke Kajimoto Senior Scientist, Scientific Affairs
MSD K.K., Japan -
Tomoyuki Kakizume, PhD
Daiichi Sankyo Co., Ltd., Japan -
Keiko Katsui, PhD Group of Social Co-Creation
Japan Agency for Medical Research and Development (AMED), Japan -
Kentaro Kogushi, PhD Head of Clinical Development Neurology-Psychiatry, Japan Development
AbbVie GK, Japan -
Yuko Kojima, RPh Sr. Executive Director
Eli Lilly Japan K.K., Japan -
Yu Komura Study Manager, Clinical Research Support Office
National Cancer Center Hospital East, Japan -
Naoki Kotani, PhD Pharmaceutical Science Dept.
Chugai Pharmaceutical Co., Ltd., Japan -
Ayaka Kubota Office of Safty II
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Misato Kuwagaki, MS Associate Director, Data Sciences
Eli Lilly Japan K.K., Japan -
Yukiko Nishimura, PhD, MSc Director
Advocacy Service for Rare and Intractable Diseases, Japan -
Fumitaka Noji Asscociate Director, Clinical Operations (Therapeutics and Oncology)
Moderna Japan Co., Ltd., Japan -
Kumiko Okada Study Manager, Clinical Operations
Pfizer R&D, Japan -
Ai Okazaki, MT Health Science Research & Development Center
Institute of Science Tokyo Hospital, Japan -
Goshi Ozawa, MS CEO
Real Discovery Outdorrs K.K., Japan -
Mikiko Shitara Senior Manager, Regulatory Affairs Dept.
Alexionpharma GK, Japan -
Keisuke Suzuki, PhD Director, Innovation Center for Translational Research
National Center for Geriatrics and Gerontology, Japan -
Tadashi Urashima, PhD Performance and Digital Analytics Lead, Japan Development
GlaxoSmithKline K.K., Japan -
Hiroto Asou Reviewer, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Koichi GOTO Deputy Manager
CM Plus Corporation, Japan -
Eri Matsunaga R&D Quality Group, R&D & PV Quality Assurance Department
Daiichi Sankyo Co., Ltd., Japan -
Futaba Nagata
PPG Service, Japan -
Noriaki Okada Clinical Operations
Eisai Co., Ltd., Japan -
Maki Yoro Office of Informatics and Management for Safety
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Kanji Hirai, RPh Director, Regulatory Policy & Intelligence, Regulatory Affair Area, Japan Dvlpmt
MSD K.K., Japan -
Noriaki Nagao, MPharm, PMP Pharmaceutical Division,Clinical Development Dept.
JAPAN TOBACCO INC., Japan -
Mitsuhiro Niimi, PhD Vice President & Managing Director, Japan
DIA, Japan
Have an account?